185 related articles for article (PubMed ID: 25294379)
1. Association between serum vitamin D and severity of liver fibrosis in chronic hepatitis C patients: a systematic meta-analysis.
Luo YQ; Wu XX; Ling ZX; Cheng YW; Yuan L; Xiang C
J Zhejiang Univ Sci B; 2014 Oct; 15(10):900-6. PubMed ID: 25294379
[TBL] [Abstract][Full Text] [Related]
2. Effect of Vitamin D Serum Levels and GC Gene Polymorphisms in Liver Fibrosis Due to Chronic Hepatitis C.
Azevedo LA; Matte U; Silveira TR; Bonfanti JW; Bruch JP; Álvares-da-Silva MR
Ann Hepatol; 2017; 16(5):742-748. PubMed ID: 28809744
[TBL] [Abstract][Full Text] [Related]
3. Is there an association between vitamin D and liver fibrosis in patients with chronic hepatitis C?
Oliveira KS; Buss C; Tovo CV
Arq Gastroenterol; 2017; 54(1):57-59. PubMed ID: 28079241
[TBL] [Abstract][Full Text] [Related]
4. Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis.
Terrier B; Carrat F; Geri G; Pol S; Piroth L; Halfon P; Poynard T; Souberbielle JC; Cacoub P
J Hepatol; 2011 Oct; 55(4):756-61. PubMed ID: 21334402
[TBL] [Abstract][Full Text] [Related]
5. Handgrip Strength and Vitamin D as Predictors of Liver Fibrosis and Malnutrition in Chronic Hepatitis C Patients.
Gabr SA; Alghadir AH
Dis Markers; 2021; 2021():6665893. PubMed ID: 33884041
[TBL] [Abstract][Full Text] [Related]
6. Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: a meta-analysis.
García-Álvarez M; Pineda-Tenor D; Jiménez-Sousa MA; Fernández-Rodríguez A; Guzmán-Fulgencio M; Resino S
Hepatology; 2014 Nov; 60(5):1541-50. PubMed ID: 24975775
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D supplementation for chronic liver diseases in adults.
Bjelakovic G; Nikolova D; Bjelakovic M; Gluud C
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011564. PubMed ID: 29099543
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D deficiency and vitamin D therapy in chronic hepatitis C.
Ladero JM; Torrejón MJ; Sánchez-Pobre P; Suárez A; Cuenca F; de la Orden V; Devesa MJ; Rodrigo M; Estrada V; López-Alonso G; Agúndez JA
Ann Hepatol; 2013; 12(2):199-204. PubMed ID: 23396730
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of vitamin D deficiency in chronic liver disease.
Arteh J; Narra S; Nair S
Dig Dis Sci; 2010 Sep; 55(9):2624-8. PubMed ID: 19960254
[TBL] [Abstract][Full Text] [Related]
10. Correlation between vitamin D levels and apoptosis in geriatric patients infected with hepatitis C virus genotype 4.
Gabr SA; Alghadir AH; Allam AA; Ajarem J; Al-Basher G; Abdel-Maksoud MA; Ghfar AA; Aboud A
Clin Interv Aging; 2016; 11():523-33. PubMed ID: 27217734
[TBL] [Abstract][Full Text] [Related]
11. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein expression predicts disease severity in chronic hepatitis C patients.
Huang CI; Huang CF; Yeh ML; Lin YH; Liang PC; Hsieh MH; Dai CY; Hsieh MY; Lin ZY; Chen SC; Huang JF; Yu ML; Chuang WL
Kaohsiung J Med Sci; 2017 Aug; 33(8):394-399. PubMed ID: 28811008
[TBL] [Abstract][Full Text] [Related]
12. Serum vitamin D₃ does not correlate with liver fibrosis in chronic hepatitis C.
Ren Y; Liu M; Zhao J; Ren F; Chen Y; Li JF; Zhang JY; Qu F; Zhang JL; Duan ZP; Zheng SJ
World J Gastroenterol; 2015 Oct; 21(39):11152-9. PubMed ID: 26494969
[TBL] [Abstract][Full Text] [Related]
13. Serum immunoreactive collagen IV detected by monoclonal antibodies as a marker of severe fibrosis in patients with non-alcoholic fatty liver disease.
Aida Y; Abe H; Tomita Y; Nagano T; Seki N; Sugita T; Itagaki M; Ishiguro H; Sutoh S; Aizawa Y
J Gastrointestin Liver Dis; 2015 Mar; 24(1):61-8. PubMed ID: 25822435
[TBL] [Abstract][Full Text] [Related]
14. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C.
Saadoun D; Asselah T; Resche-Rigon M; Charlotte F; Bedossa P; Valla D; Piette JC; Marcellin P; Cacoub P
Hepatology; 2006 Jun; 43(6):1337-45. PubMed ID: 16729318
[TBL] [Abstract][Full Text] [Related]
15. The association between serological and dietary vitamin D levels and hepatitis C-related liver disease risk differs in African American and white males.
White DL; Tavakoli-Tabasi S; Kanwal F; Ramsey DJ; Hashmi A; Kuzniarek J; Patel P; Francis J; El-Serag HB
Aliment Pharmacol Ther; 2013 Jul; 38(1):28-37. PubMed ID: 23710689
[TBL] [Abstract][Full Text] [Related]
16. Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients.
Petta S; Grimaudo S; Marco VD; Scazzone C; Macaluso FS; Cammà C; Cabibi D; Pipitone R; Craxì A
J Viral Hepat; 2013 Jul; 20(7):486-93. PubMed ID: 23730842
[TBL] [Abstract][Full Text] [Related]
17. Serum fibrosis markers identify patients with mild and progressive hepatitis C recurrence after liver transplantation.
Carrión JA; Fernández-Varo G; Bruguera M; García-Pagán JC; García-Valdecasas JC; Pérez-Del-Pulgar S; Forns X; Jiménez W; Navasa M
Gastroenterology; 2010 Jan; 138(1):147-58.e1. PubMed ID: 19786026
[TBL] [Abstract][Full Text] [Related]
18. Significance of biglycan and osteopontin as non-invasive markers of liver fibrosis in patients with chronic hepatitis B virus and chronic hepatitis C virus.
Sobhy A; Fakhry M M; A Azeem H; Ashmawy AM; Omar Khalifa H
J Investig Med; 2019 Mar; 67(3):681-685. PubMed ID: 30385593
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D and histologic severity of nonalcoholic fatty liver disease: A systematic review and meta-analysis.
Jaruvongvanich V; Ahuja W; Sanguankeo A; Wijarnpreecha K; Upala S
Dig Liver Dis; 2017 Jun; 49(6):618-622. PubMed ID: 28274829
[TBL] [Abstract][Full Text] [Related]
20. Simple non-invasive markers as a predictor of fibrosis and viral response in chronic hepatitis C patients.
Arabul M; Aslan F; Alper E; Akpinar Z; Çelık M; Kandemır A; Vatansever S; Ünsal B
Turk J Gastroenterol; 2012; 23(5):538-45. PubMed ID: 23161299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
